The Mesothelioma Center News – Page 14
-
newsAsbestos Exposure & BansThe U.S. Environmental Protection Agency proposed a potentially historic ban April 5 that would prohibit all current uses of chrysotile asbestos. Chrysotile is the…
-
newsLegislation & Litigation
Senate Passes Asbestos Awareness Resolution, Inches Closer to Ban
The U.S. Senate unanimously passed its annual National Asbestos Awareness Week resolution, inching closer to long-awaited, much-anticipated legislation to ban the toxic substance. The… -
newsAsbestos Exposure & Bans
Past Asbestos Testing on Inmates Could Affect J&J Talc Lawsuits
Johnson & Johnson funded a study more than 50 years ago at a Philadelphia prison that injected asbestos into a small number of… -
newsLegislation & Litigation
$36.5 Million Verdict Could Change Asbestos Litigation in Libby, Montana
A Montana District Court jury recently delivered a $36.5 million verdict in a bellwether case that is expected to significantly change the landscape of… -
newsLegislation & Litigation
Johnson & Johnson’s Talc Bankruptcy Plan Approved
Much to the ire of plaintiff attorneys across the country, a federal judge in New Jersey granted approval for Johnson & Johnson to… -
newsResearch & Clinical Trials
Mesothelioma Clinical Trial Matches Treatment to Genetic Profiles
Scientists at the University of Leicester in the United Kingdom recently published phase 2 clinical trial results involving abemaciclib, a new genetic therapy for… -
newsResearch & Clinical Trials
NCI Moving Closer to More Effective Treatment for Pleural Mesothelioma
A research team at the National Cancer Institute is developing a novel therapy that could change the treatment paradigm for pleural mesothelioma. -
newsAsbestos Exposure & Bans
FDA Looks at Stricter Testing for Asbestos in Talc
The U.S. Food and Drug Administration recently moved a step closer to a much-needed, stricter standardization of testing for the presence of toxic… -
newsResearch & Clinical Trials
NCI Opens New Immunotherapy Clinical Trial for Mesothelioma
The National Cancer Institute has opened a promising clinical trial aimed at increasing the effectiveness of immunotherapy treatment for patients with unresectable malignant… -
newsResearch & Clinical Trials
Clinical Trials Lead to Promising Updates in Mesothelioma Immunotherapy
Researchers have made significant progress in mesothelioma treatment advancements recently, including promising work with immunotherapy. The first U.S. Food and Drug Administration-approved combination…